1.LiY WangJ LiC KeXY。 Contribute to FPD-l 1 targeted therapy based on lymphomas and tumor-related genes. leuklymphoma . 20 12 CT； 53( 10):20 15-23.(IF2.30 1)
2. Wang, Yang, Gao, Zhou. clinicalandlaboratory systemanaplasticallarcelllymphomainchinesepatients . jhematoloncol . 20 12 jul 7； 5( 1):38.(IF4.458)
3. Jing Wong, Jing Hongmei, CoCo Lee, Dong Fei, Chen Yuping, Ke Xiaoyan. Clinical characteristics and treatment of 14 patients with extramedullary plasmacytoma. China Cancer Clinic 2014,41(10): 639-642.
4. Wan,, Ke Xiaoyan. Research progress of hodgkin's lymphoma. Leukemia and lymphoma 2014; 23(5):308 - 3 10.
5. Wan,,, Jing Hongmei,,,, Ke Xiaoyan. Clinicopathological features and prognosis of 92 cases of primary diffuse large B-cell lymphoma of gastrointestinal tract. Chinese Journal of Hematology 2014,35 (4): 288-294.
6. Hu Kai,,,,, Li, Ke Xiaoyan. Comparative study of fludarabine replacing cyclophosphamide in myeloablative pretreatment chemotherapy combined with allogeneic hematopoietic stem cell transplantation for acute leukemia. Leukemia and lymphoma 2014; 23(2):79-83.
7. Zhu Mingxia, Jing Wong, Ke Xiaoyan. Effects of different extracellular matrices on the differentiation of human embryonic stem cells into hematopoietic progenitor cells. Journal of Experimental Hematology 2014; 22( 1): 148- 153.
8. Andy, Wan, Hu Kai and Ke Xiaoyan. Clinical characteristics and prognosis of 59 cases of follicular lymphoma. Journal of Experimental Hematology 2013; 2 1(6): 1448- 1453.
9. Hu Kai, Wang Jijun, Zhao Wei, Tian Lei, Wan Wei, Ke Xiaoyan. Long-term follow-up and curative effect observation of autologous peripheral blood hematopoietic stem cell transplantation for malignant lymphoma. Journal of Experimental Hematology 2013; 2 1(6): 147 1- 1476.
10. Jing Hongmei, CoCo Lee, Jing Wong, Gao Zifen and Ke Xiaoyan. Diffuse large B-cell lymphoma secondary to solitary myeloma: a case report and literature review. Leukemia and lymphoma 2013; 22( 1 1):748-750.
1 1. Andy,,,,, Hu Kai, Ke Xiaoyan. Survival, efficacy and safety of combined chemotherapy in the treatment of newly diagnosed follicular lymphoma. Leukemia and lymphoma 2013; 22( 1 1):650-657.
120,000,,, Andy, Jing Hongmei,,, Hou Shuling, Ke Xiaoyan. Clinical features and prognosis of 62 cases of Hodgkin's lymphoma. Chinese Journal of Hematology 2013,34 (7): 618-621.
13. Andy, Jing Wong and Ke Xiaoyan. Main progress in biological research of Hodgkin's lymphoma at the 54th annual meeting of American Hematology Society. Leukemia and lymphoma 2013; 22(7):385-386。
140,000,, Ke Xiaoyan. Application of PET-CT in Hodgkin's lymphoma: Report of the 54th Annual Meeting of American Hematology Society. Leukemia and lymphoma 2013; 22(7):387-388。
15. Wang xiaocan, Jing Wong, ke Xiaoyan. Application of cytokines and bone marrow transplantation in the treatment of acute radiation sickness. China Journal of Radiation and Protection 2013; 33(3):225-227。
Wan Wei, Dong Fei, Jing Wong, Feng Kaichao, Su Liping, Su Xu, Ke Xiaoyan. Clinical application of hematopoietic growth factor in iatrogenic acute radiation sickness. China Journal of Radiation and Protection 2013; 33(3):228-23 1。
17. Dong Fei, Jing Wong, Wang Jijun, Hu Kai, Tian Lei, Wan Wei, Feng Kaichao, Su Liping, Su Xu, Ke Xiaoyan. Effect of whole body radiotherapy on hematopoietic reconstruction after autologous stem cell transplantation and its short-term adverse reactions. China Journal of Radiation and Protection 2013; 33(3):232-234。
18. Tian Lei, Ke Xiaoyan. Principles of Treatment and Radiotherapy for Localized Hodgkin's Lymphoma: Report of the 54th Annual Meeting of American Hematology Society. Leukemia and lymphoma 2013; 22(5):257-258。
19. Li Yi, Jing Wong, Ke Xiaoyan. The expression of PD-L 1 in lymphoma and its resistance to lymphoma proliferation and chemotherapy. Journal of Experimental Hematology 2013; 2 1(2):366-370。
20. Zhao Wei, Yang Ping, Jing Wong, Jing Hongmei and Ke Xiaoyan. Effect of bortezomib combined with adriamycin on lymphoblastic lymphoma Molt-4 cells. Leukemia and lymphoma 2013; 22(3): 132- 135。
2 1. Zhao Wei, Dong Fei, Jing Wong, Ke Xiaoyan. Clinical analysis of 26 cases of lung injury after chemotherapy in patients with malignant hematological tumor. Leukemia and lymphoma 2013; 22(2):94-97。
22. Wang Xiaocan and Ke Xiaoyan. Research progress on etiology and pathogenesis of MALT lymphoma. Journal of Experimental Hematology 2012; 20(6): 1526– 1530。
23. Zhu Mingxia and Ke Xiaoyan. The role of microRNA in the development and differentiation of lymphocytes and the occurrence of malignant tumors in lymphatic system. Journal of Experimental Hematology 2012; 20(4): 10 14– 10 19。
24. Tian Lei, Wang Jijun, Wang Zhao and Ke Xiaoyan. A case of adult primary hemophagocytic syndrome. Chinese Journal of Hematology 2012; 33( 10):8 18.
25. Li, Ke Xiaoyan. Research progress of Notch signaling pathway in B-cell malignant tumor. Leukemia and lymphoma 2012; 2 1(7):439-44 1。
26. Li,,, Ke Xiaoyan. Effect of chidamide on human b lymphoma cell line and its mechanism. Journal of Experimental Hematology 2012; 20(4):893-899.
27. Yang Ping, Jing Wong, Dong Fei, Jing Hongmei and Ke Xiaoyan. Retrospective analysis of 9 1 case of T-cell non-Hodgkin's lymphoma. Leukemia and lymphoma 2012; 2 1(5):264-268。
28. Hu Kai, Wang Yanfang, Jing Wong and Ke Xiaoyan. Study on lenalidomide enhancing cytokine-induced cytotoxicity. Leukemia and lymphoma 2012; 2 1(5):257-260。
29. Dong Fei, Ke Xiaoyan. Research progress of primary mediastinal B-cell lymphoma. Leukemia and lymphoma 2012; 2 1(4):243-245。
30. Li Yi, Ke Xiaoyan. An ideal treatment for advanced Hodgkin lymphoma. Leukemia and lymphoma 2012; 2 1(2):68-69。
3 1. Yang Ping, Ke Xiaoyan. Long-term side effects of modern treatment for Hodgkin's lymphoma. Leukemia and lymphoma 2012; 2 1( 1): 13- 15。
32. Li, Ke Xiaoyan. Application of PET-CT in the treatment of hodgkin's lymphoma. Leukemia and lymphoma 2012; 2 1( 1): 15- 18。
33. Li, Ke Xiaoyan. Expression and significance of Notch signal molecules in human lymphoma cells. Journal of Experimental Hematology 2012; 20( 1):83-87.